Skip to main content
    N

    Novo Nordisk A/S (NVO)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE

    $40.70
    -0.89 (-2.15%)

    Market Cap: $183.52B

    Last updated: Nov 17, 2026 at 5:28 PM ET

    Novo Nordisk A/S (NVO) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Novo Nordisk A/S (NVO) has a latest price of $40.70 on Nov 17, 2026, 33.4% below its 52-week high of $61.11. Its price fell 12.7% over the past 12 months. The month-end price rose 125.1% over the 10 years through Oct 2026, a compound annual rate of 8.5%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $142.74 in Jun 2024 and its lowest $16.80 in Nov 2016, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart NVO with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NVO.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 12.4%, and over 6 months it fell 6.9%. The month-end price fell 58.6% over the 3 years through Oct 2026, a compound annual decline of 25.5%.

    PeriodChange
    1 month+5.9%
    3 months-12.4%
    6 months-6.9%
    12 months-12.7%
    12 months, with dividends-8.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-58.6%-25.5%
    5 years-27.4%-6.2%
    10 years+125.1%+8.5%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2021, when the price rose 60.3%, and its weakest was 2025, when it fell 40.9%.

    YearCloseChange
    2026 through Oct 2026$40.00-21.4%
    2025$50.88-40.9%
    2024$86.02-16.8%
    2023$103.45+52.9%
    2022$67.67+20.8%
    2021$56.00+60.3%
    2020$34.92+20.7%
    2019$28.94+25.6%
    2018$23.04-14.2%
    2017$26.84+49.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 2.0% above its 50-day average of $39.90 and 4.1% below its 200-day average of $42.46.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$40.70
    52-week high$61.11-33.4%
    52-week low$34.15+19.2%
    50-day average$39.90+2.0%
    200-day average$42.46-4.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 75.0%.

    MeasureValue
    1-year beta0.95
    Largest fall, 1 year-44.4%
    Largest fall, 3 years-75.0%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About NVO

    What is NVO's 1-year price change?

    Novo Nordisk A/S's price fell 12.7% over the past 12 months. With dividends included, the 12-month total return was -8.9%.

    What is NVO's 5-year price change?

    Novo Nordisk A/S's month-end price fell 27.4% over the 5 years through Oct 2026, a compound annual decline of 6.2%. These figures leave out dividends.

    What is NVO's 52-week high and low?

    Novo Nordisk A/S's 52-week high is $61.11 and its 52-week low is $34.15. Its latest price of $40.70 on Nov 17, 2026 is 33.4% below the high.

    What is NVO's beta?

    Novo Nordisk A/S's 1-year beta against the S&P 500 is 0.95, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 44.4%.

    Is the NVO chart free?

    Yes. Advanced Charting for NVO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.